Skip to content

KTTA

Pasithea Therapeutics Corp.

NASDAQ · Healthcare · Biotechnology · US

$0.41
−1.83%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
27.55x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
0.28x
Price / sales
—
Price / cash flow
-0.77x

Enterprise value

Enterprise value
-$31.9M
EV / sales
—
EV / EBITDA
1.37x
EV / EBIT
1.33x
Market cap
$13.8M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026